Diagnosis and Treatment of Cutaneous Mastocytosis in Children
- 1 August 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in American Journal of Clinical Dermatology
- Vol. 12 (4), 259-270
- https://doi.org/10.2165/11588890-000000000-00000
Abstract
Cutaneous mastocytosis in children is a generally benign disease that can present at birth and is often associated with mast cell mediator-related symptoms including pruritus, flushing, and abdominal pain with diarrhea. The most common form of presentation is urticaria pigmentosa, also referred to as maculopapular mastocytosis. Flares of lesions are induced by triggers such as physical stimuli, changes in temperature, anxiety, medications, and exercise. The skin lesions are typically present on the extremities. Symptoms respond to topical and systemic anti-mediator therapy including antihistamines and cromolyn sodium. Remission at puberty is seen in a majority of cases. Progression to systemic mastocytosis with involvement of extracutaneous organs is not common. The cause of cutaneous mastocytosis is unknown and familial cases are rare. Mutations of c-kit have been observed in the skin of those affected. The diagnosis is established on clinical grounds and the findings on skin biopsy. Bone marrow studies are recommended if there is suspicion of progression of disease to an adult form, if cytoreductive therapy is contemplated, or if skin lesions remain present and/or tryptase levels remain elevated after puberty. The use of chemotherapy, including kinase inhibitors, is strongly discouraged unless severe hematologic disease is present, since malignant evolution is extremely rare.Keywords
This publication has 103 references indexed in Scilit:
- Pediatric Mastocytosis: Routine Anesthetic Management for a Complex DiseaseAnesthesia & Analgesia, 2008
- Topical Sodium Cromoglycate in the Treatment of Moderate-to-Severe Atopic DermatitisAnnals of Allergy, Asthma & Immunology, 1998
- Referred for Management of MastocytosisAnnals of Allergy, Asthma & Immunology, 1997
- Novel Histamine H3 Receptor Antagonists: Synthesis and Evaluation of Formamidine and S-Methylisothiourea Derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1997
- Value of urinary N-methylhistamine measurements in childhood mastocytosisJournal of the American Academy of Dermatology, 1996
- The mast cell and mast cell diseaseJournal of the American Academy of Dermatology, 1995
- Urticaria pigmentosa: An anesthetic challengeJournal of Clinical Anesthesia, 1990
- Quantification of cutaneous mast cells using morphometric point counting and a conjugated avidin stainJournal of the American Academy of Dermatology, 1987
- Treatment of bullous mastocytosis with disodium cromoglycateJournal of the American Academy of Dermatology, 1983
- Oral Disodium Cromoglycate in the Treatment of Systemic MastocytosisThe New England Journal of Medicine, 1979